NEXTWAVE PHARMACEUTICALS Inc — Form D

NEXTWAVE PHARMACEUTICALS Inc of CUPERTINO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2011-01-25. The offering totals $45.5M, of which $27.2M was reported sold. Industry: Pharmaceuticals.

Offering

Filed: 2011-01-25
Form: D
Accession: 0001389718-11-000004
Industry: Pharmaceuticals
Exemptions: 06
Total offering: $45.5M
Amount sold: $27.2M
Remaining: $18.3M
Investors: 11
Date of first sale: 2011-01-10
Security types: equity
Revenue range: Decline to Disclose
SEC file number: 021-154302

Issuer

Name: NEXTWAVE PHARMACEUTICALS Inc
CIK: 0001389718
Entity type: Corporation
Jurisdiction: DELAWARE
Address: 20450 STEVENS CREEK BOULEVARD, CUPERTINO, CA, 95014
Phone: 4083421300

Officers, directors & promoters (14)

Name	Role	Location
Gaurav Aggarwal	Director	Palo Alto, CA
Robert Casale	Director	Burlingame, CA
Steve Elms	Director	New York, NY
Hingge Hsu	Director	Cupertino, CA
Frank Kung	Director	EMERYVILLE, CA
Anand Mehra	Director	Wayne, PA
Dayton Misfeldt	Director	Waltham, MA
Jay Shepard	Director	Dallas, TX
Patrick Zenner	Director	Cupertino, CA
Linda Ara	Executive Officer	Sunnyvale, CA
Sally Berry	Executive Officer	Cupertino, CA
Michael Burdick	Executive Officer	Chicago, IL
Craig Chambliss	Executive Officer	Cupertino, CA
Jay Shepard	Executive Officer	Dallas, TX

More